Noninvasive detection of lung transplant dysfunction using breath tests
Official title: Noninvasive Early Detection of Lung Allograft Dysfunction After Lung Transplantation With Multiple Breath Washout Test: Lung Clearance Index as an Early Marker
Run by University of Zurich · NCT05586906 · Data updated 2026-11-12
This study is testing a breath test to see if it can help find early signs of lung transplant rejection in patients three months after their surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | University of Zurich Academic / other |
| Locations | 1 site (Zurich) |
| Status | Recruiting |
| Started | March 1, 2023 |
| Main results expected | April 1, 2024 |
| Study ends | January 1, 2027 |
| Registry record updated | May 16, 2023 |
| Trial ID | NCT05586906 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals who have undergone bilateral lung transplantation at Zurich University Hospital.
✕Probably not a fit
Patients who have undergone retransplantation will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to detect chronic rejection, known as bronchiolitis obliterans syndrome (BOS), in lung transplant recipients through a noninvasive method called Multiple Breath Washout (MBW) tests. By measuring lung clearance index (LCI) three months post-transplant, the study seeks to identify early signs of BOS, which is a leading cause of mortality after the first year of transplantation. Early detection may allow for timely treatment adjustments to improve patient outcomes. Approximately 90 participants from Zurich University Hospital will be involved in this assessment.
Why it matters
Potential benefit: If successful, this approach could lead to earlier interventions that significantly improve survival rates for lung transplant recipients.
How similar studies have gone: Other studies have shown promise in using noninvasive methods for early detection of transplant dysfunction, making this approach both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All recipients who underwent bilateral lung transplantation at Zurich University Hospital will be included. Exclusion Criteria: * Retransplantation
Where it's running
-
University Hospital Zurich
Zurich, Switzerland Recruiting
Study contacts
- Principal investigator: Carolin Steinack, MD — University of Zurich
- Study coordinator: Carolin Steinack, MD
- Email: carolin.steinack@usz.ch
- Phone: 0041442551111
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Long-term outcomes after vacuum-induced tamponade for postpartum hemorrhage
This study will look at women who had postpartum hemorrhage treated with vacuum-induced tamponade at a Zurich hospital to see how they fared over time, including future pregnancies and fertility.
-
Add-on Sildenafil Before Exercise in PAH to See if Max Workload Improves
This study tests whether taking 20 mg sildenafil right before exercise helps people with pulmonary arterial hypertension perform more work during cardiopulmonary testing.
-
Fatigue Investigation Using Digital Outcomes
This study tests whether digital monitoring with a smartphone app and wearables can track fatigue in people with MS or long COVID, compared with healthy volunteers.
-
Impact of ambient air vs nasal liquid oxygen on exercise performance in pulmonary vascular disease
This study tests whether using nasal liquid oxygen during a 6-minute walk test changes how far patients with PAH or CTEPH can walk compared to breathing room air.
-
Liquid oxygen vs ambient air during a 6-minute walk in people with pulmonary vascular disease
This study tests whether walking with liquid oxygen at about 4 L/min helps or hinders distance walked compared with walking on room air in adults with PAH or CTEPH living in Switzerland.
-
Daily adjustment of radiation dose in MRI-guided SBRT for abdominal and pelvic tumors
This trial tests whether adjusting the radiation dose in real-time during MRI-guided SBRT improves targeting for abdominal or pelvic tumors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.